ADRA2A antibody (Adrenergic, alpha-2A-, Receptor) (C-Term)

Details for Product anti-ADRA2A Antibody No. ABIN2196811
Antigen
Epitope
C-Term
15
13
10
4
3
2
2
2
2
2
2
2
1
1
1
Reactivity
Human
90
56
54
4
4
4
4
3
2
2
1
1
1
1
Host
Rabbit
93
8
Clonality
Polyclonal
Conjugate
This ADRA2A antibody is un-conjugated
6
4
4
4
4
4
4
3
3
2
2
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (IHC), Western Blotting (WB)
49
32
25
23
14
13
7
7
4
3
1
Options
Immunogen Synthetic peptide corresponding to a sequence mapping near the C-terminal of human ADRA2, identical to the related rat and mouse sequence.
Isotype IgG
Cross-Reactivity Human, Mouse (Murine), Rabbit, Rat (Rattus)
Cross-Reactivity (Details) Calculated cross reactivity: Hu Mo Rb Rt
Characteristics ADRA2A (Alpha-2A Adrenergic Receptor, Alpha-2 Adrenergic Receptor Subtype C10, Alpha-2A Adrenoreceptor, Alpha-2A Adrenoceptor, Alpha-2AAR, ADRA2R, ADRAR)
Purification Purified by immunoaffinity chromatography.
Antigen
Alternative Name ADRA2A (ADRA2A Antibody Abstract)
UniProt P08913
Pathways EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
Application Notes Optimal working conditions should be determined by the investigator.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute with sterile dH2O.
Buffer Supplied as a lyophilized powder from PBS, pH 7.4, 5 % BSA, 0.05 % thimerosal, 0.05 % sodium azide.
Preservative Sodium azide, Thimerosal (Merthiolate)
Precaution of Use This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
Storage -20 °C
Storage Comment -20°C